Showing results (71-80 of 438) with videos related to
Sort By:
Pageof 44
Cancers|April 3, 2021
Liver Transplantation for T2 Hepatocellular Carcinoma during the COVID-19 Pandemic: A Novel Model Balancing Individual Benefit against Healthcare ResourcesUmberto Cillo, Alessandro Vitale, Michael L Volk, et al.Tumori|June 30, 2020
Outcome of patients with colorectal cancer undergoing lung metastases resection: a single-institution retrospective analysisMarco Mammana, Francesca Bergamo, Letizia Procaccio, et al.Clinical Pharmacokinetics|August 14, 2025
Clinical Pharmacology Profile of the Claudin 18.2 Antibody ZolbetuximabJianning Yang, Akihiro Yamada, Kohei Shitara, et al.International Journal of Molecular Sciences|March 27, 2025
Circulating Tumor DNA as a Real-Time Biomarker for Minimal Residual Disease and Recurrence Prediction in Stage II Colorectal Cancer: A Systematic Review and Meta-AnalysisSilvia Negro, Alessandra Pulvirenti, Chiara Trento, et al.Journal of Neurology, Neurosurgery, and Psychiatry|July 2, 2013
Early predictors of oxaliplatin-induced cumulative neuropathy in colorectal cancer patientsRoser Velasco, Jordi Bruna, Chiara Briani, et al.Journal of Cancer Research and Clinical Oncology|January 14, 2016
Development of an oncological-multidimensional prognostic index (Onco-MPI) for mortality prediction in older cancer patientsAntonella Brunello, Andrea Fontana, Valeria Zafferri, et al.Cancer Cell International|February 5, 2020
The heterogeneous clinical and pathological landscapes of metastatic Braf-mutated colorectal cancerGiuseppe Nicolò Fanelli, Carlo Alberto Dal Pozzo, Ilaria Depetris, et al.BMC Cancer|January 12, 2026
Conversion surgery vs. standard of care in pancreaTic cancer oligometastatic to the liver (SONAR: Surgery in Oligometastatic paNcreatic cAnceR) a randomized controlled trialRiccardo Guastella, Giampaolo Perri, Domenico Bassi, et al.BMC Gastroenterology|January 11, 2022
Complete pathological response of colorectal peritoneal metastases in Lynch syndrome after immunotherapy case report: is a paradigm shift in cytoreductive surgery needed?Marco Tonello, Floriana Nappo, Loretta Vassallo, et al.Journal for Immunotherapy of Cancer|November 10, 2019
Treatment with checkpoint inhibitors in a metastatic colorectal cancer patient with molecular and immunohistochemical heterogeneity in MSI/dMMR statusFotios Loupakis, Giulia Maddalena, Ilaria Depetris, et al.Pageof 44